Drug intelligence / Profile preview

Yonatrevon

Development stage
Unknown
Lead developer
Pescado
Modality
Small Molecules
Administration
Oral
01

Overview

Yonatrevon is a multi-ingredient oral supplement developed by Pescado Pharmaceuticals, an Egyptian company. It is formulated as a capsule containing 300 mg of alpha-lipoic acid in combination with vitamin B6 (pyridoxine), vitamin B12 (cobalamin), and folic acid. The product is indicated for nervous system support and the management of peripheral neuropathy. Alpha-lipoic acid serves as a potent antioxidant that scavenges reactive oxygen species to mitigate oxidative damage in nerve cells. The B-vitamins and folic acid act as essential cofactors in metabolic pathways critical for nerve repair, myelin synthesis, and neurotransmitter production. It is currently approved and marketed for these indications.

Brand names
Yonatrevon
Other names
Yonatrevon CapsulesAlpha-lipoic acid 300 mg + Vitamin B6 + Vitamin B12 + Folic acid
02

Targets

1C metabolism (One-carbon metabolism)DDC (Aromatic L-amino acid decarboxylase)Nucleotide synth (Nucleotide synthesis enzymes)

Beyond the preview

Go deeper on Yonatrevon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yonatrevon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call